Enzymatics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Enzymatics Inc. - overview
Established
2006
Location
Beverly, MA, US
Primary Industry
Biotechnology
About
Enzymatics Inc. specializes in providing high-quality enzymes and related products for molecular biology, enhancing capabilities in DNA and protein research for diverse scientific applications. Founded in 2006 in Beverly, US, Enzymatics Inc. develops enzymes essential for molecular biology applications.
The company was acquired by Qiagen in January 2015 from PBM Capital Group. Specific details on the founder or prior companies are not available. Enzymatics Inc. focuses on developing and supplying enzymes that facilitate DNA manipulation, PCR amplification, sequencing, and gene cloning, catering to academic institutions, clinical laboratories, and pharmaceutical companies.
Their products aim to support scientific inquiries and enhance biotechnological advancements on a global scale. Enzymatics Inc. generates revenue primarily through direct sales of its enzyme products to customers and through partnerships with distributors. Their offerings include customized enzyme solutions tailored to laboratory needs, which strengthen customer relationships and ensure satisfaction.
Following its acquisition by Qiagen, Enzymatics Inc. is expected to leverage Qiagen's resources to enhance product offerings and expand into new markets. While specific upcoming product launches have not been detailed, the integration aims to utilize recent funding to support growth initiatives and market expansion into regions like Europe and Asia-Pacific by the end of 2023.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Scientific Software
Website
www.enzymatics.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Enzymatics Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Enzymatics Inc. | - | ||||||||
| Buyout | Completed | Enzymatics Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.